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Abstract
Background: Monomicrobial necrotizing fasciitis is rapidly progressive and life-threatening. This study was
undertaken to ascertain whether the clinical presentation and outcome for patients with this disease differ for
those infected with a gram-positive as compared to gram-negative pathogen.
Methods: Forty-six patients with monomicrobial necrotizing fasciitis were examined retrospectively from
November 2002 to January 2008. All patients received adequate broad-spectrum antibiotic therapy, aggressive
resuscitation, prompt radical debridement and adjuvant hyperbaric oxygen therapy. Eleven patients were infected
with a gram-positive pathogen (Group 1) and 35 patients with a gram-negative pathogen (Group 2).
Results: Group 2 was characterized by a higher incidence of hemorrhagic bullae and septic shock, higher APACHE
II scores at 24 h post-admission, a higher rate of thrombocytopenia, and a higher prevalence of chronic liver
dysfunction. Gouty arthritis was more prevalent in Group 1. For non-survivors, the incidences of chronic liver
dysfunction, chronic renal failure and thrombocytopenia were higher in comparison with those for survivors. Lower
level of serum albumin was also demonstrated in the non-survivors as compared to those in survivors.
Conclusions: Pre-existing chronic liver dysfunction, chronic renal failure, thrombocytopenia and hypoalbuminemia,
and post-operative dependence on mechanical ventilation represent poor prognostic factors in monomicrobial
necrotizing fasciitis. Patients with gram-negative monobacterial necrotizing fasciitis present with more fulminant
sepsis.
Background
Necrotizing fasciitis is characterized by a rapidly spread-
ing necrosis of the superficial fascia and subcutaneous
tissue and is associated with a high mortality despite
aggressive surgical treatment and adequate parenteral
antibiotic therapy [1]. This disease is generally classified
into the following categories: Type 1 (polymicrobial
infection), Type 2 (infection with a Group A b-haemoly-
tic Streptococcus or Staphylococcus aureus), and Type 3
(infection with a gram-negative bacillus such as Vibrio)
[2-4]. The incidence of monomicrobial necrotizing fas-
ciitis has recently increased [5-8]. The soft tissue
necrosis that typifies these infections is attributable to
the release of endotoxins, exotoxins and proteases that
threaten the microcirculation leading to vascular throm-
bosis and may further serve to promote the extension of
complex soft tissue injury [9]. Accurate early diagnosis
and surgical intervention combined with administration
of appropriate parenteral antibiotics have been the cor-
nerstones of necrotizing fasciitis treatment. In addition,
hyperbaric oxygen therapy was suggested to improve the
microcirculation such that wound healing migh be
enhanced and provide an adjunctive alternative to surgi-
cal debridement for treatment of necrotizing fasciitis
[10-12].
Prognosis for the patient with necrotizing fasciitis is
heavily dependent on initiation of appropriate empiric
antibiotic treatment. Therefore, approaches that can
assist the physician in the rapid identification of
the responsible microbial pathogen are needed. It is
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prognosis for patients with monomicrobial necrotizing
fasciitis differ as a function of infection with a gram-
positive as compared to a gram-negative pathogen. The
purposes of this study were to compare the clinical
characteristics of patients suffering from these two
classes of monomicrobial necrotizing fasciitis and to
evaluate the effects of treatments including parenteral
antibiotics, debridement and hyperbaric oxygen therapy
on these two classes of infection. It was hoped that such
information would serve to predict more accurately the
outcome for patients with monomicrobial necrotizing
fasciitis as well as to provide a guide for better manage-
ment of this disease.
Methods
Patients
Between November 2002 and January 2008, there were
61 patients diagnosed as necrotizing fasciitis who under-
went fasciectomy in conjunction with hyperbaric oxygen
therapy in Chang Gung Memorial Hospital at Chia Yi.
Among them, there were 46 patients with monomicro-
bial necrotizing fasciitis were included. There were
other 7 patients with polymicrobial necrotizing fasciitis
and still other 8 patients with necrotizing fasciitis with-
out any pathogen being isolated from ether blood or
soft tissue. Approval for this study was obtained from
the Chang Gung Memorial Hospital Institutional Review
Board (CGMH-992193B). Necrotizing fasciitis was
defined by surgical findings, including the presence of
grayish necrotic skin, subcutaneous fat and fascia, no
resistance of normally adherent fascia to digital blunt
dissection, and a purulent discharge resembling foul-
smelling dish water. Histopathological tissue specimens
were obtained to confirm the diagnoses [13]. Monomi-
crobial infection was demonstrated by isolation of single
bacteria from soft tissue or blood collected in the Emer-
gency Department (ED) and during surgery.
Treatments and clinical parameters
The treatment protocol included broad-spectrum anti-
biotic therapy, aggressive resuscitation, prompt radical
debridement, adjuvant hyperbaric oxygen (HBO) ther-
apy, and soft tissue reconstruction. Empiric antibiotic
therapy with oxacillin and gentamicin was usually pre-
scribed upon suspicion of necrotizing fasciitis infection.
However, when a Vibrio infection was suspected based
on a recent history of exposure to sea water or raw sea
food, a third-generation cephalosporin and tetracycline
were administered instead of oxacillin and gentamycin.
Intensive care and aggressive resuscitation, including
challenge with fluids and inotropic agents, were given to
maintain mean arterial pressure above 65 mm Hg [14].
Emergent surgery with endotracheal tube insertion and
general anesthesia was performed for all patients.
Criteria for ICU admission used at this hospital were
based on recommendations of the American College of
Critical Care Medicine and the Society of Critical Care
Medicine [15]. Patients with multiple co-morbidities,
shock or hemodynamic unstable status (systolic blood
pressure < 90 mmHg or 20 mm Hg below the patient’s
usual pressure or mean arterial pressure < 65 mm Hg)
were transferred to ICU for intensive care. Mechanical
ventilation support was applied in all patients during
operation and continued for patients with postoperative
respiratory failure. When hemodynamic status became
stable, mechanical ventilation was discontinued. Further
surgical debridement was performed every other day if
progressive necrotic changes combined with a deteriorat-
ing clinical presentation were observed. Adjuvant HBO
therapy was initiated after patients’ extubation and trans-
fer from the intensive care unit to general ward, and con-
tinued once daily for 120 minutes. The treatment
protocol of HBO therapy was 10 times initially and
adjusted according to patients’ response. Soft tissue
reconstruction was performed until local infection and
soft tissue was relatively stabilized. The reconstruction
methods included split thickness skin graft and free vas-
cular myocutaneous flap. The reconstruction methods
varied according to the degree of soft tissue defect. All
reconstruction surgery was performed by plasty surgeons.
Patients with monomicrobial necrotizing fasciitis were
divided into two groups according to the result of gram
staining for further analyses: those with infections due
to gram-positive cocci (Group 1) and those with infec-
tions due to gram-negative bacilli (Group 2). Clinical
parameters including age, gender, co-morbidities, pre-
senting signs and symptoms, location of infection,
laboratory findings at the time of admission, bacteriolo-
gical findings, Laboratory Risk Indicator for Necrotizing
Fasciitis (LRINEC) score [16], Acute Physiological, Age,
and Chronic Health Evaluation (APACHE) II score [17],
length of hospital stay, and outcomes such as survival
and limb salvage were recorded and compared.
Statistical analyses
Statistical analyses were performed using the Statistical
Package for the Social Sciences for Windows (SPSS, ver-
sion 12.0). The Fisher’s exact test was used for discon-
tinuous variables, and Wilcoxon rank sum test was used
for continuous variables. Statistical significance was set
at a p-value of < 0.05.
Results
Clinical characteristics and presentation of patients with
monobacterial necrotizing fasciitis
The demographic and clinical characteristics of the
forty-six patients with monomicrobial necrotizing
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sented in Table 1. The median patient age was 63 years
(range, 22-85). Thirty-five (76%) patients were male.
The lower limbs were more frequently involved (67.4%).
Thirty-four (74%) patients were immunocompromised;
18 of these patients had diabetes mellitus, 19 had
chronic liver dysfunction, 9 had chronic renal failure
(Cr > 1.6 mg/dL) [18] including 2 with end-stage-renal
d i s e a s e ,a n d4h a dah i s t o r yo fm a l i g n a n c y( o n ec a s eo f
lung cancer, one of bladder cancer, and 2 of hepatocel-
lular carcinoma). Eleven (23.9%) patients were infected
with a gram-positive cocci (Group 1), and 35 (76.1%)
were infected with a gram-negative bacillus (Group 2).
Of the gram-positive cocci, Staphylococcus aureus was
the most commonly isolated (54.5%), followed by beta-
hemolytic Streptococcus (36.3%) and S. viridans(9.1%). In
six Staphylococcus aureus,f o u rw e r eMethicillin-Sensi-
tive Staphylococcus aureus(MSSA), and two were
Methicillin-Resistant Staphylococcus aureus(MRSA).
Vibrio species were the most commonly isolated of the
gram-negative bacilli (65.7%). Among them, 20 were
Vibrio vulnificus(60.0%). The followings were Aeromonas
spp., which were isolated in 8 (22.9%) patients, and one
case each (2.9%) of K. pneumonia, Escherichia coli and
Pseudomonas Stutzeri was identified. Prevotella spp., an
anaerobic gram-negative bacterium, was found in one
(2.9%) patient.(Table 2)
No significant differences in the parameters of age,
gender, upper versus lower limb involvement and time
to first surgical intervention were observed between
Groups 1 and 2 (Table 1). The duration of symptoms
prior to admission to the ED was longer for patients in
Group 1 (p < 0.001). Patients with a history of gout
were more highly represented in Group 1 (p = 0.005)
whereas patients with chronic liver dysfunction were
more highly represented in Group 2 (p = 0.016). In
Table 1 Group comparison of characteristics (Table 1)
Gram positive
pathogen (n = 11)
Gram Negative
pathogen (n = 35)
p value
Age 59 (34, 72) 64(22, 85) 0.138
Gender(Male/Female) 9/2 26/9 1.000
Involved region
Upper extremity 5 (45.5) 10 (28.6) 0.462
Lower extremity 6 (54.5) 25 (71.4)
TiOA(day) 7.18 (2, 14) 2.43 (0.5, 14)* < 0.001
TiOS(hour) 25.64 (2, 72) 11.74 (1, 72)* 0.046
Immunocompromised(DM, liver dysfunction, Chronic renal failure,
Malignancy)
5 (45.5) 29 (82.8)* 0.022
Comorbidity
DM 5 (45.5) 13 (37.1) 0.728
Gout 5 (45.5) 2 (5.7)* 0.005
Chronic renal failure (> 1.6 mg/dL) 2 (18.2) 7 (20) 1.000
Chronic Liver dysfunction 1 (9.1) 18 (51.4)* 0.016
HBV 0 (0) 11 (31.4)* 0.044
HCV 1 (9.1) 11 (31.4) 0.241
HBV or HCV 1 (9.1) 17 (48.6)* 0.032
Liver cirrhosis 0 8 (22.9) 0.619
ICU stay(patient number) 4 (36.4) 26 (74.3)* 0.032
Post-operative mechanical ventilation (patient number) 4 (36.4) 24 (68.6) 0.080
APACHE II score 12.9 (3, 21) 18.9 (2, 34)* 0.015
ICU stay (day) 2 (0, 7) 4.3 (0, 16) 0.077
Hospital stay (day) 35.7 (15, 70) 35.8 (13, 87) 0.800
Amputation 0 5 (10.9) 0.317
STSG 5 (45.5) 21 (60) 0.494
Free flap transfer 1 (9.1) 7 (20) 0.658
Mortality 1(9.1) 6(17.1) 1.000
Data are presented as median (min, max) or frequency (%).
TiOA: duration of symptoms prior to arrival in the ERTiOS: time of the first surgical intervention from arrival in the ER.
APACHE: Acute Physiological, Age, and Chronic Health Evaluation.
Chronic liver dysfunction: liver cirrhosis, viral hepatitis(HBV, or HCV)STSG: split thickness skin graft.
*: The difference is significant (p < 0.05).
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highly represented in Group 2 (p = 0.022), and mean
APACHE II scores at 24 h post-admission were higher
for Group 2 (12.9 versus 18.9, p = 0.015).
All patients presented to the ED with an erythema-
tous, tender, swelling lesion (100% for both groups) but
the proportion of patients presenting with shock and
hemorrhagic bullae was higher in Group 2 (p = 0.009
and p = 0.013, respectively; Table 3). The mean WBC
count was increased in both groups and the increased
percentage of immature leucocytes was also noted in
both groups. Thrombocytopenia was more frequently
observed in Group 2 (p = 0.044). The mean LRINEC
score for Group 1 was significantly higher than that for
G r o u p2( 6 . 2a n d4 . 5 ,p = 0.025). No significant differ-
ences in bacteremia, C-reactive protein, hemoglobin,
glucose, sodium, or albumin findings were observed
between the two groups. (Table 4)
Characteristics of surviving and non-surviving patients
No significant differences in the parameters of age, gen-
der, infection location, or isolated pathogenic bacterium
were observed between surviving and non-surviving
patients. (Table 5) However, mortality among patients
with chronic liver dysfunction or chronic renal failure
was higher (p = 0.015 and 0.02, respectively). Mortality
was also higher for patients with reduced serum albu-
min values, thrombocytopenia, and immature leukocyte
more than 10%(p = 0.036, and 0.008, and 0.015, respec-
tively). All non-surviving patients required mechanical
ventilation and transfer to the ICU after the first surgi-
cal intervention (p = 0.032) and had longer stays in the
ICU (p < 0.0002). The mean LRINEC score and its com-
ponents, including hemoglobin, C-reactive protein,
glucose, and sodium values, did not differ between
survivors and non-survivors. (Table 6)
Discussion
Findings of the present strongly support the concept
that patients with monobacterial necrotizing fasciitis due
to gram-negative bacilli present with different clinical
parameters and predisposing co-morbidities as com-
pared to patients with monobacterial necrotizing fasciitis
due to gram-positive cocci. A greater number of patients
with chronic liver dysfunction resulting from HBV infec-
tion, HCV carrier status or cirrhosis were infected with
gram-negative as opposed to gram-positive organisms.
By contrast, a larger number of patients with gouty
arthritis were infected with gram-positive cocci as
opposed to gram-negative bacilli. These findings agree
with those of Lee et al[8]. who found gram-negative
bacillary infections to predominate among 42 cirrhotic
patients with monobacterial necrotizing fasciitis. Addi-
tionally, Yu et al [19]. observed a prevalence of gram-
positive cocci infections among 15 gouty patients with
monobacterial necrotizing fasciitis. In the present study,
differences in characteristics and laboratory findings
were observed between patients with necrotizing fasciitis
due to gram-positive cocci as opposed to gram-negative
bacillary infections. The latter group presented with a
shorter duration of symptoms prior to arrival at the ED
and more frequently with hemorrhagic bullae, septic
shock, and thrombocytopenia. Group 2 patients also had
higher APACHE II scores within 24 h of admission,
indicating that the severity of disease was greater for
this group [17]. Accordingly, cirrhotic patients with
gram-negative bacillary necrotizing fasciitis were found
to be especially prone to concurrent bacteremia and
septic shock [8]. More aggressive resuscitation, intensive
care and debridement is therefore recommended when
gram-negative bacillary necrotizing fasciitis is suspected
based upon a history of exposure, coexisting disease,
clinical manifestations, and laboratory findings.
T h em o r t a l i t yr a t ef o rn e c r otizing fasciitis is high
(cumulative average of 34%), and the limb amputation
r a t ei nt h i sd i s e a s ei sr e p o r t e dt ob ea sh i g ha s5 0 %
Table 2 Summary of microbiology
Gram positive pathogen (n = 11)
Staphylococcus aureus 6(54.5%)
MSSA 4
MRSA 2
Streptococcus sp.
Alpha-hemolytic 1(9.1%)
S. viridans 1
Beta-hemolytic 4(36.3%)
S. pyogenes 1
Group B streptoccus 3
Gram negative pathogen (n = 35)
Vibrio spp. 23(66%)
Vibrio vulnificus 20
Vibrio parahaemolyticus 2
Vibrio cholerae non-O1 1
Aeromonas spp. 8(23%)
Aeromonas hydrophila 6
Aeromonas sobria 1
Aeromonas caviae 1
Kleb.pneumoniae 1
E. Coli 1
Pseudomonas Stutzeri 1
Anaerobes
Prevotella spp. 1
Data are presented as frequency (%).
MRSA: Methicillin-Resistant Staphylococcus aureus.
MSSA: Methicillin-Sensitive Staphylococcus aureus.
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was 15.2% whereas the limb amputation rate was 10.9%
under the treatment protocol employed. No significant
difference in mortality rate was observed between
patients with infections due to gram-positive pathogens
and those with infections due to gram-negative patho-
gens (9.09% versus 17.14%, p = 1.000). Antibiotic thera-
pies were chosen based on clinical presentation at the
ED: a third-generation cephalosporin plus tetracycline
when a gram-negative pathogen such as Vibrio or Aero-
monas was suspected, and oxacillin plus gentamicin
when a gram-positive pathogen was suspected [21-24].
It is well-established that immediate wide excision of all
necrotic soft tissue and appropriate antibiotic therapy
are essential for a positive clinical outcome. In the cur-
rent study, hyperbaric oxygen therapy was included in
the treatment protocol to further optimize clinical out-
comes. Adjuvant hyperbaric oxygen therapy improves
neutrophil function, fibroblast proliferation and collagen
secretion, each of which is important in infection con-
trol and wound coverage. It was possible mortality and
amputation rates might be reduced by adjuvant hyperba-
ric oxygen therapy [10,11]. For example, Wilkinson et al
reported that hyperbaric oxygen therapy significantly
reduced the incidence of amputation in a retrospective
cohort study of 44 subjects with necrotizing fasciitis
patients [1]. By contrast Hassan et al, who treated 67
comparable subjects with hyperbaric oxygen recently
found no significant benefit [25]. The characteristic of
present study was monomicrobial necrotizing fasciitis
receiving adjunctive hyperbaric oxygen therapy. The pre-
sent study demonstrated the mortality and amputation
Table 3 Group comparison of signs and symptoms
Symptoms and signs Gram positive pathogen (n = 11) Gram negative Pathogen (n = 35) p-value
Fever (> 38.3°C) 8 (72.7) 16 (45.7) 0.171
Hypothemia (< 35°C) 1 (9.0) 4(11.4) 1
Pain and tenderness 11 (100) 35 (100) 1
Swelling and erythema 11 (100) 35 (100) 1
Hemorrhagic bullae 0 (0) 15 (42.9)* 0.009
Shock(< 90 mmHg) 2 (18.2) 23 (65.7)* 0.013
Inotropic support 2 (18.2) 19 (54.3)* 0.045
Data are presented as frequency (%).
*: The difference is significant (p < 0.05).
Table 4 Group comparison of laboratory data
Laboratory data Gram positive pathogen (n = 11) Gram Negative pathogen (n = 35) p-value
Total WBC
Leukocytosis(> = 12,000/ul) 8 (72.7) 23 (65.7) 1.000
Leukopenia(< = 4,000/ul) 0 4 (11.4) 0.559
Leukocytosis or leukopenia 8 (72.7) 27 (77.1) 1.000
Differential count
Band formation 9 (81.8) 33 (94.3) 0.238
Band ≧ 10% 3 (27.3) 16 (45.7) 0.320
neutrophilia(> 7,500/ul) 8 (72.7) 25 (71.4) 1.000
Lymphocytopenia(< 1,000/ul) 2 (18.2) 19 (54.3)* 0.045
Thrombocytopenia(< 150,000/ul) 0 12 (34.3)* 0.044
Bacteremia 7 (63.6) 17 (48.6) 0.497
Hemoglobin(g/dL) 12.4 (10.0, 14.1) 12.6 (7.7, 15.8) 0.690
C-reactive protein (mg/dL) 178.0 (50, 373) 114.0 (24.4, 354) 0.302
Glucose (mg/dL) 265.4 (121, 842) 164.14(91, 436) 0.065
Sodium (meq/L) 132.4 (124, 136) 135.3 (127, 141)* 0.044
Hypoalbuminemia(< 3 g/dL) 6 (54.5) 24 (68.6) 0.477
LRINEC score 6.18 (4, 10) 4.51 (0, 12)* 0.031
Data are presented as median (min, max) or frequency (%).
Chronic liver dysfunction: liver cirrhosis, viral hepatitis (HBV, or HCV).
LRINEC: Laboratory Risk Indicator for Necrotizing Fasciitis.
*: The difference is significant (p < 0.05).
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Survivors(n = 39) Deaths (n = 7) p value
Age 62 (22, 85) 68 (55, 78) 0.668
Gender
Male 30 (76.9) 6 (85.7) 1.000
Female 9 (23.1) 1 (14.3)
Underlying disease
Viral hepatitis 13 (33.3) 5 (71.4) 0.093
Liver cirrhosis 4 (10.2) 4 (57.1)* 0.012
Chronic liver dysfunction 13 (33.3) 6 (85.7)* 0.015
Diabetes mellitus 16 (41.0) 2 (28.6) 0.688
Chronic renal failure 5 (12.8) 4 (57.1)* 0.020
Immunocompromised(DM, liver dysfunction, CRF, malignancy) 27 (69.2) 7 (100) 0.165
Pathogens
Gram positive pathogen 10 (25.6) 1 (14.3) 0.667
Gram negative pathogen 29 (74.4) 6 (85.7)
Involved region
Upper extremity 11 (28.2) 4 (57.1) 0.193
Lower extremity 28 (71.8) 3 (42.9)
Shock at ER 19 (48.7) 6 (85.7) 0.106
Data are presented as median (min, max) or frequency (%)
Chronic liver dysfunction: liver cirrhosis, viral hepatitis (HBV, or HCV)
*: The difference is significant (p < 0.05)
Table 6 Comparison of laboratory data between survivals and deaths
Survival n = 39 non-survival n = 7 p-value
Total WBC
Leukocytosis(> 12,000/ul) 27 (69.2) 4 (57.1) 0.667
Leukopenia(< 4,000/ul) 2 (5.1) 2 (28.6) 0.104
Leukocytosis or leukopenia 29 (74.3) 6 (85.7) 0.667
Differential count
Band formation 35 (89.7) 7 (100) 1.000
neutrophilia(> 7,500/ul) 29 (74.3) 4 (57.1) 0.385
lymphocytopenia(< 1,000/ul) 16 (41.0) 5 (71.4) 0.220
Thrombocytopenia(< 150,000/ul) 7 (17.9) 5 (71.4) 0.009
Hemoglobin(g/dL) 12.6 (7.7, 15.8) 12.4 (10.0, 14.7) 0.866
C-reactive protein (mg/dL) 135 (50, 373) 97 (63, 227) 0.915
Glucose (mg/dL) 194.9 (90, 842) 152 (105, 264) 0.667
Sodium (meq/L) 134.6(124, 141) 134.4 (127, 140) 0.988
Creatinine > 1.6 mg/dL 5 (12.8) 4 (57.1)* 0.020
Hypoalbuminemia(< 3 g/dL) 22 (56.4) 7 (100)* 0.036
LRINEC score 5.1 (0, 12) 3.7 (0, 70 0.217
APACHE II 16.9 (2, 34) 21.3 (17, 27) 0.090
ICU stay (patient numbers) 23 (59.0) 7 (100) 0.078
post-OP ventilator (patient numbers) 21 (53.8) 7 (100)* 0.032
ICU stay (day) 2.5 (0, 16) 10.3 (7, 14)* < 0.001
Hospital stay(day) 36 (13, 87) 34.6 (14, 79) 0.635
Data are presented as median (min, max) or frequency (%)
APACHE, acute physiological, age, and chronic health evaluation
Chronic liver dysfunction: liver cirrhosis, viral hepatitis(HBV, or HCV)
*: The difference is significant (p < 0.05)
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More well-designed, prospective, case controlled stu-
dies are warranted to assess the potential benefit of
adjuvant hyperbaric oxygen therapy in necrotizing
fasciitis.
The present study identified chronic liver dysfunction,
chronic renal failure, initial thrombocytopenia, hypoal-
buminemia, dependence on post-surgical mechanical
ventilation, and a longer ICU stay as risk factors for
mortality in monobacterial necrotizing fasciitis. These
observations agree well with those of others. Liver cir-
rhosis and cancer, as well as severe hypoalbuminemia,
thrombocytopenia, serum creatinine values exceeding 2
mg/dL, and an increase in the band form of leukocytes
were previously reported as risk factors for mortality in
necrotizing fasciitis.
[8,26] Furthermore, post-operative
dependence on mechanical ventilation and a longer ICU
stay, indicating respiratory failure and sepsis, are
reported to serve as factors predictive of amputation
and death for such patients [19]. Physicians should
therefore be aware of the grave prognosis for patients
with necrotizing fasciitis and who present with pre-
existing chronic liver dysfunction or chronic renal fail-
ure, with thrombocytopenia, or with hypoalbuminemia.
Limitations of the present study should be addressed.
First, the number of patients examined was small. Sec-
ond, the patient cohort was derived from a consecutive
series of patients who presented to one hospital over a
nine-year period; findings may therefore be influenced
by diseases indigenous to a particular region over a
given time period. In this regard, chronic liver dysfunc-
tion is known to be prevalent in Taiwan currently.
Third, patients were placed in groups based on gram-
stain findings rather than on identification of the speci-
fic pathogen responsible for the infection. Although
important initial findings were obtained using this
approach, the ultimate goal is to characterize the effects
of individual bacterial pathogens on the presentation
and outcome for patients with monobacterial necrotiz-
ing fasciitis.
In summary, a higher incidence of hemorrhagic bul-
lae and septic shock, higher APACHE II scores, a
higher rate of thrombocytopenia, and a higher preva-
lence of chronic liver dysfunction was observed for
patients presenting with monobacterial fasciitis due a
gram-negative as compared to a gram-positive patho-
gen. In contrast, gouty arthritis was found to be more
prevalent among subjects with monobacterial fasciitis
due to infection by a gram-positive as compared to a
gram-negative organism. For non-survivors of mono-
bacterial necrotizing fasciitis, the incidences of chronic
liver dysfunction, chronic renal failure and thrombocy-
topenia were higher, and serum albumin values were
lower.
Conclusion
Pre-existing chronic liver dysfunction, chronic renal
failure, thrombocytopenia and hypoalbuminemia, and
post-operative dependence on mechanical ventilation
represent poor prognostic factors in monomicrobial necro-
tizing fasciitis. Patients with gram-negative monobacterial
necrotizing fasciitis present with more fulminant sepsis.
Treatment protocols which include aggressive resuscita-
tion, rapid administration of antibiotics and immediate
surgical intervention are recommended for all patients
presenting with monomicrobial necrotizing fasciitis.
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